Skip to main content

David Tabernero Caellas

Institutions of which they are part

Senior researcher
Liver Diseases
Vall Hebron Institut de Recerca

David Tabernero Caellas

Institutions of which they are part

Senior researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

(Standard-D) Standardization of HDV-RNA quantification: a need that can no longer be ignored.

IP: -
Collaborators: David Tabernero Caellas, Ariadna Rando Segura
Funding agency: Gilead Sciences, S.L.U.
Funding: 49961.71
Reference: GLD22/00080
Duration: 28/02/2023 - 28/02/2026

Malalties hepàtiques

IP: Joan Genescà Ferrer
Collaborators: Beatriz Minguez Rosique, Sergi Colomer Castell, Elena Vargas Accarino, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Maria Buti Ferret, Montserrat Gomez Perez, Judit Romero Vico, Josep Quer Sivila, Adriana Palom Agusti, Juan Manuel Pericàs Pulido, Malalties hepàtiques, Damir Garcia Cehic, Laura Puente Ramo, Isabel Campos Varela, María Bermúdez Ramos, Juan Ignacio Esteban Mur, Ester Palacio Gutierrez, Susana Anton Calvo, Monica Higuera Urbano, Meritxell Ventura Cots, Ares Aurora Villagrasa Vilella, Emma Bigas Alsina, Carolina Campos Martinez, Macarena Simon-Talero Horga, David Tabernero Caellas, Mònica Pons Delgado, Marcella Salzano
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00462
Duration: 01/01/2022 - 30/06/2025

Optimización del algoritmo diagnóstico para el cribado de infección por virus de la hepatitis D en la población atendida en el área de cobertura de la sanidad pública de la ciudad de Barcelona.

IP: Ariadna Rando Segura
Collaborators: Maria Buti Ferret, David Tabernero Caellas, Maria Francesca Cortese
Funding agency: Gilead Sciences, S.L.U.
Funding: 27000
Reference: GILEAD/HEPATITIS/2022/RANDO
Duration: 22/02/2023 - 30/09/2025

Estudio de la quasiespecies del gen X en ARN circulante del virus de la hepatitis B (ARN-VHB): en búsqueda de nuevos factores pronósticos y dianas para terapia génica.

IP: -
Collaborators: Lluis Castells Fusté, Andrea Caballero Garralda, David Tabernero Caellas, Maria Francesca Cortese
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI18/01436
Duration: 01/01/2019 - 31/12/2022

Related news

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

This tool will help avoid invasive techniques and assist in selecting candidates for clinical trials of new treatments.

The meetings served to share advances in translational research and consolidate international scientific alliances in the study of liver diseases

Related professionals

Gloria Aparicio Español

Gloria Aparicio Español

Biomedical Research in Melanoma
Read more
Carla Soto Santoyo

Carla Soto Santoyo

Research technician
Kidney Physiopathology
Read more
Judith Martínez Lacambra

Judith Martínez Lacambra

Tècnic/a Superior Recerca
Clinical Trials Management Unit
Clinical Research Development Directorate
Read more
Alba Márquez Gallego

Alba Márquez Gallego

Research technician
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.